Werkgroep Cardiologische centra Nederland English

RED-HF (Klaar)

Reduction of Events with Darbepoetin alfa in Heart Failure. A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Subjects With HF and Anemia.
Middel
darbepo√ętine
Populatie
hartfalen
Fase
III
Jaar aanvang
2006
Meer informatie
ClinicalTrials.gov

Studiedirecteur

dr. G.C.M. Linssen (Cardioloog)
Almelo, ZGT

RED-HF: Nieuws